148 related articles for article (PubMed ID: 23955800)
1. Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis.
He YZ; Hu X; Chi XS; Zhang YC; Deng XB; Wei MT; Wang ZQ; Zhou YH
Tumour Biol; 2014 Jan; 35(1):615-21. PubMed ID: 23955800
[TBL] [Abstract][Full Text] [Related]
2. 135G/C polymorphism in the RAD51 gene and acute myeloid leukemia risk: a meta-analysis.
Wu L; Long ZG; Dai ZS
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173193
[TBL] [Abstract][Full Text] [Related]
3. Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.
Zeng X; Zhang Y; Yang L; Xu H; Zhang T; An R; Zhu K
Medicine (Baltimore); 2018 Jun; 97(26):e11251. PubMed ID: 29952992
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of RAD51 and XRCC3 and acute myeloid leukemia risk: a meta-analysis.
Li C; Liu Y; Hu Z; Zhou Y
Leuk Lymphoma; 2014 Jun; 55(6):1309-19. PubMed ID: 23978154
[TBL] [Abstract][Full Text] [Related]
5. Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.
Wang W; Li JL; He XF; Li AP; Cai YL; Xu N; Sun SM; Wu BY
PLoS One; 2013; 8(9):e75153. PubMed ID: 24040396
[TBL] [Abstract][Full Text] [Related]
6. Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.
Zhang BB; Wang DG; Xuan C; Sun GL; Deng KF
Fam Cancer; 2014 Dec; 13(4):515-26. PubMed ID: 24859942
[TBL] [Abstract][Full Text] [Related]
7. RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis.
Cheng D; Shi H; Zhang K; Yi L; Zhen G
Diagn Pathol; 2014 Jan; 9():18. PubMed ID: 24457040
[TBL] [Abstract][Full Text] [Related]
8. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
Wang Z; Dong H; Fu Y; Ding H
Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
[TBL] [Abstract][Full Text] [Related]
9. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
Gao LB; Pan XM; Li LJ; Liang WB; Zhu Y; Zhang LS; Wei YG; Tang M; Zhang L
Breast Cancer Res Treat; 2011 Feb; 125(3):827-35. PubMed ID: 20640595
[TBL] [Abstract][Full Text] [Related]
10. RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.
Yu KD; Yang C; Fan L; Chen AX; Shao ZM
Breast Cancer Res Treat; 2011 Apr; 126(2):365-71. PubMed ID: 20461453
[TBL] [Abstract][Full Text] [Related]
11. RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.
Sekhar D; Pooja S; Kumar S; Rajender S
Sci Rep; 2015 Jun; 5():11588. PubMed ID: 26108708
[TBL] [Abstract][Full Text] [Related]
12. 135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.
Smolarz B; Samulak D; Michalska M; Góralczyk B; Szyłło K; Lewy J; Sporny S; Kokołaszwili G; Burzyński M; Romanowicz-Makowska H
Pol J Pathol; 2011 Sep; 62(3):157-62. PubMed ID: 22102073
[TBL] [Abstract][Full Text] [Related]
13. RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis.
Zhou GW; Hu J; Peng XD; Li Q
Breast Cancer Res Treat; 2011 Jan; 125(2):529-35. PubMed ID: 20623332
[TBL] [Abstract][Full Text] [Related]
14. The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.
Shi S; Qin L; Tian M; Xie M; Li X; Qi C; Yi X
Tumour Biol; 2014 Jun; 35(6):5797-804. PubMed ID: 24599673
[TBL] [Abstract][Full Text] [Related]
15. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
[TBL] [Abstract][Full Text] [Related]
16. RAD51 Gene 135G/C polymorphism and ovarian cancer risk: a meta-analysis.
Hu X; Sun S
Int J Clin Exp Med; 2015; 8(12):22365-70. PubMed ID: 26885215
[TBL] [Abstract][Full Text] [Related]
17. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
18. Association between
Zhou T; Yin SJ; Wang P; Fan YX; Li ZR; Yang Q; Huang YH; Meng R; He GH
Hematology; 2021 Dec; 26(1):1046-1056. PubMed ID: 34895100
[TBL] [Abstract][Full Text] [Related]
19.
Yazdanpanahi N; Salehi R; Kamali S
J Cancer Res Ther; 2018; 14(3):614-618. PubMed ID: 29893328
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.
Gonçalves AC; Alves R; Baldeiras I; Cortesão E; Carda JP; Branco CC; Oliveiros B; Loureiro L; Pereira A; Nascimento Costa JM; Sarmento-Ribeiro AB; Mota-Vieira L
Mol Carcinog; 2017 Jan; 56(1):130-148. PubMed ID: 26950655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]